NCT00037544
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +15 more
- Locations
-
Not specified
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,038 public trials
2,028 recruiting studies
Lymphoproliferative Disorders trial results
NCT00661401
- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Common Variable Immunodeficiency, +9 more
- Locations
-
- Division of Allergy, Clinical Immunology and Rheumatology, Department of Pediatrics, Federal University of São Paulo São Paulo, Brazil
Completed
Fasturtec TLS Treatment / Prophylysis
NCT00651911
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +3 more
- Locations
-
- Sanofi-Aventis Bridgewater, New Jersey, United States
NCT00633542
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Clinica di ematologia ospedali riuniti ancona università politecnica delle marche Ancona, Italy
NCT00211198
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- Yale University School of Medicine New Haven, Connecticut, United States
- The University of Iowa Iowa City, Iowa, United States
- New England Medical Center Boston, Massachusetts, United States
NCT00050999
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- University of Texas, M.D. Anderson Cancer Center Houston, Texas, United States
- Level 4 Department of Haematology Royal North Shore Hospital Saint Leonard's, New South Wales, Australia
- Westmead Hospital, Department of Haematology Westmead, New South Wales, Australia
- Mater Misericordiae Adult Hospital South Brisbane, Queensland, Australia
Completed
Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients
NCT00051012
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- University of Texas, M.D. Anderson Cancer Center Houston, Texas, United States
- Level 4 Department of Haematology Royal North Shore Hospital Saint Leonard's, New South Wales, Australia
- Westmead Hospital, Department of Haematology Westmead, New South Wales, Australia
- Mater Misericordiae Adult Hospital South Brisbane, Queensland, Australia
NCT00001750
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States
Completed
Stem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients With Blood Cancer
NCT00005785
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Bone Marrow Diseases, +39 more
- Locations
-
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Bethesda, Maryland, United States
NCT00001444
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +21 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States